The increase in CXCL1 expression in Barrett’s esophagus and esophageal adenocarcinoma is also due to the frequent amplification of the CXCL1 gene as well as hypomethylation of its promoter [59]. This evidence concerns the gene CXCL1 and Barrett esophagus.